21.36
Precedente Chiudi:
$21.63
Aprire:
$21.49
Volume 24 ore:
442.75K
Relative Volume:
0.50
Capitalizzazione di mercato:
$2.69B
Reddito:
$2.12B
Utile/perdita netta:
$29.73M
Rapporto P/E:
120.41
EPS:
0.1774
Flusso di cassa netto:
$162.20M
1 W Prestazione:
+0.21%
1M Prestazione:
-7.39%
6M Prestazione:
-9.63%
1 anno Prestazione:
-7.91%
Privia Health Group Inc Stock (PRVA) Company Profile
Nome
Privia Health Group Inc
Settore
Industria
Telefono
571-366-8850
Indirizzo
950 N. GLEBE RD., SUITE 700, ARLINGTON
Compare PRVA vs VEEV, BTSG, TEM, HQY, HNGE
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
PRVA
Privia Health Group Inc
|
21.36 | 2.73B | 2.12B | 29.73M | 162.20M | 0.1774 |
|
VEEV
Veeva Systems Inc
|
168.78 | 28.17B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
BTSG
Brightspring Health Services Inc
|
58.31 | 11.32B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
47.80 | 8.34B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HQY
Healthequity Inc
|
87.90 | 7.41B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
HNGE
Hinge Health Inc
|
63.88 | 4.92B | 646.34M | -512.40M | 202.76M | -6.6871 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-09 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-11-13 | Iniziato | BMO Capital Markets | Outperform |
| 2025-01-10 | Iniziato | Needham | Buy |
| 2024-12-16 | Iniziato | Macquarie | Outperform |
| 2024-10-11 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Iniziato | Robert W. Baird | Outperform |
| 2024-04-22 | Iniziato | Citigroup | Buy |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Ripresa | Jefferies | Buy |
| 2024-02-22 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-12-06 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-06-13 | Iniziato | Evercore ISI | Outperform |
| 2023-04-12 | Iniziato | Stephens | Overweight |
| 2023-03-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-02-03 | Iniziato | Goldman | Buy |
| 2022-12-09 | Iniziato | Stifel | Buy |
| 2022-12-08 | Iniziato | UBS | Buy |
| 2022-09-07 | Ripresa | Truist | Buy |
| 2022-05-03 | Iniziato | BofA Securities | Buy |
| 2022-04-28 | Iniziato | BTIG Research | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-03-30 | Iniziato | Guggenheim | Buy |
| 2022-02-22 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2022-01-03 | Iniziato | Jefferies | Buy |
| 2021-09-27 | Iniziato | SVB Leerink | Outperform |
| 2021-09-10 | Iniziato | Cowen | Market Perform |
| 2021-05-24 | Iniziato | Canaccord Genuity | Buy |
| 2021-05-24 | Iniziato | Credit Suisse | Outperform |
| 2021-05-24 | Iniziato | JP Morgan | Overweight |
| 2021-05-24 | Iniziato | Piper Sandler | Overweight |
| 2021-05-24 | Iniziato | Truist | Buy |
| 2021-05-24 | Iniziato | William Blair | Outperform |
Mostra tutto
Privia Health Group Inc Borsa (PRVA) Ultime notizie
Privia Health Group, Inc. - MLQ.ai
What Privia Health Group (PRVA)'s New Jersey Neurology Anchor Deal Means For Shareholders - simplywall.st
Understanding Momentum Shifts in (PRVA) - Stock Traders Daily
How The Privia Health Group (PRVA) Narrative Is Shifting With Mixed Targets And New Deals - Yahoo Finance
Q1 Rundown: Privia Health (NASDAQ:PRVA) Vs Other Healthcare Technology for Providers Stocks - Yahoo Finance
PRVA News | PRIVIA HEALTH GROUP INC (NASDAQ:PRVA) - ChartMill
A Look at Privia Health Group Inc (PRVA) After 3.4% Gain -- GF V - GuruFocus
Privia Health earnings on deck as analysts eye provider expansion - Investing.com
PRVA Technical Analysis | Trend, Signals & Chart Patterns | PRIVIA HEALTH GROUP INC (NASDAQ:PRVA) - ChartMill
Is Privia Health Stock a Buy After Hedge Fund Rubicon Founders Added Over 175,000 Shares to Its Position? - The Globe and Mail
Is Privia Health Stock a Buy After Hedge Fund Rubicon Founders Added Over 175,000 Shares to Its Position? - The Motley Fool
Free cash flow per share of Privia Health Group, Inc. – NASDAQ:PRVA - TradingView
Physician network Privia Health enters New Jersey - ROI-NJ
Privia Health Group Enters New Jersey - Moomoo
Privia Health expands to New Jersey, partnering with Neurology Group of Bergen County. - Pluang
New Jersey neurology care to expand as Privia joins 25-clinician group - Stock Titan
PRVA Maintained by Barclays -- Price Target Lowered to $24.00 - GuruFocus
Avoiding Lag: Real-Time Signals in (PRVA) Movement - Stock Traders Daily
PRVA Q1 2026 Earnings: Profit Miss Overshadowed by Slight Stock GainGuidance Accuracy Score - The Legal Advocate
Privia Health Group shareholders approve all proposals at annual meeting By Investing.com - Investing.com India
Privia Health Group, Inc. 8-K Filing May 2026: Executive Compensation Vote Results and Company Information - Minichart
Privia Health Group shareholders approve all proposals at annual meeting - Investing.com
Privia Health (PRVA) director receives 8,463 restricted stock units as equity award - Stock Titan
Privia Health (PRVA) director receives 8,463 restricted stock units in equity grant - Stock Titan
Privia Health (PRVA) director awarded 8,463 restricted stock units in equity grant - Stock Titan
Privia Health (PRVA) director awarded 8,463 RSUs in equity grant - Stock Titan
Privia Health (PRVA) director McCarthy granted 8,463 RSUs and updates holdings - Stock Titan
Privia Health Group (PRVA) director awarded 8,463 restricted stock units - Stock Titan
Privia Health Group (PRVA) director Jaewon Ryu granted 8,463 restricted stock units - Stock Titan
Director at Privia Health (PRVA) receives 8,463 RSU grant as board compensation - Stock Titan
Privia Health (PRVA) director Francis Soistman files initial Form 3 with no holdings - Stock Titan
Privia Health (NASDAQ: PRVA) holders approve directors, pay and auditor - Stock Titan
A Look At Privia Health Group (PRVA) Valuation After Q1 Results And Maintained 2026 Revenue Guidance - simplywall.st
BMO Capital Initiates Coverage of Privia Health Group (PRVA) with Outperform Recommendation - MSN
Privia Health Group CEO & Director Parth Mehrotra Sells 47% Of Holding - simplywall.st
What to expect from Privia Health’s (PRVA) Q1 earnings - MSN
Discipline and Rules-Based Execution in PRVA Response - Stock Traders Daily
Privia Health Group's (NASDAQ:PRVA) Earnings May Just Be The Starting Point - simplywall.st
Statutory Profit Doesn't Reflect How Good Privia Health Group's (NASDAQ:PRVA) Earnings Are - Yahoo Finance
Privia Health Group Insider Sold Shares Worth $2,731,898, According to a Recent SEC Filing - Moomoo
Insider Selling: Privia Health Group (NASDAQ:PRVA) CEO Sells 105,439 Shares of Stock - MarketBeat
Privia Health CEO sells over $2.7m in company stock - Investing.com
Privia Health CEO sells over $2.7m in company stock By Investing.com - Investing.com Nigeria
[Form 4] Privia Health Group, Inc. Insider Trading Activity - Stock Titan
Privia Health CFO David Mountcastle sells $76,501 in stock - Investing.com UK
Privia Health Group (NASDAQ:PRVA) CFO Sells $76,501.00 in Stock - MarketBeat
Privia Health CFO David Mountcastle sells $76,501 in stock By Investing.com - Investing.com South Africa
Privia Health (PRVA) CFO tax-driven sale of 3,385 shares disclosed - Stock Titan
Earnings call transcript: Privia Health Q1 2026 misses EPS but beats revenue By Investing.com - Investing.com South Africa
Earnings call transcript: Privia Health Q1 2026 misses EPS but beats revenue - Investing.com Nigeria
Privia Health Group Inc Azioni (PRVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Privia Health Group Inc Azioni (PRVA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Mehrotra Parth | Chief Executive Officer |
May 12 '26 |
Sale |
22.64 |
15,647 |
354,248 |
434,357 |
| Mountcastle David | EVP & Chief Financial Officer |
May 11 '26 |
Sale |
22.60 |
3,385 |
76,501 |
211,462 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):